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Available online 24 February 2011Abstract Background/aims: By ectopic expression of a distinct combination of transcription factors we aimed to induce a
mature hepatocyte phenotype in an adult liver derived progenitor cell population (ALDPC). Methods: The open reading frames
encoding murine Foxa2, Hnf4α and C/ebpα were cloned into lentivirus vectors and sequentially expressed in target cells. After
seven days of culture, cells were analysed for expression of liver specific genes, and functional assays were performed. Fresh
primary hepatocytes, twenty four hours in culture, served as positive controls. Results: Untransduced ALDPC under established
differentiation conditions exhibited moderate signs of maturation, in particular in comparison with fresh hepatocyte controls.
In transcription factor transduced cells, fifteen mRNA´s coding for secreted proteins, cytochrome p450 isoenzymes, liver
metabolic enzymes were detected by RT-qPCR at levels close to controls. Albumin secretion increased incrementally in single
(Foxa2), double (Foxa2, Hnf4α) and triple-transduced cells (Foxa2, Hnf4α, C/ebpα) and reached levels observed in primaryAbbreviations: ALDPC, adult liver-derived progenitor cells; iPS, induced pluripotent stem cells; LETF, liver enriched transcription factors;
LD, liver differentiation medium; HBM, hepatocyte basal medium; MM, maintenance medium; ESC, embryonic stem cells; Foxa2, forkhead box
protein A2; Hnf4α, hepatocyte nuclear factor 4 alpha; C/ebpα, CCAAT/enhancer binding protein alpha; Alb, Albumin; Aat, alpha-1-
antitrypsin; Tat, tyrosine aminotransferase; Tdo2, tryptophan 2,3-dioxygenase; G6p, glucose-6-phosphatase; Cldn1, claudin 1; Cps1,
carbamoyl-phosphate synthetase 1; Gys2, glycogen synthase 2; Fah, fumarylacetoacetate hydrolase; Cyp, cytochrome P450; Pxr, pregnane X
receptor; Apo, apolipoprotein
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252 R. Iacob et al.hepatocytes. Glycogen storage as determined by PAS staining was detectable in double and triple transduced cells, comparable
to controls. Ureagenesis was also induced in triple transduced cells, but at lower levels compared to primary hepatocytes.
Conclusions: Sequential expression of Foxa2, Hnf4α and C/ebpα induces a mature hepatocyte phenotype in an expandable liver
derived progenitor cell line.
© 2011 Elsevier B.V. All rights reserved.IntroductionThe isolation of high quality hepatocytes from organs and
tissues for toxicological studies and clinical therapies
remains a challenge and alternative cellular resources are
urgently needed. Various protocols for directed hepatic
differentiation of stem cells have been developed as
alternatives for large scale hepatocyte production. Embry-
onic and, more recently, induced pluripotent stem (iPS) cells
where shown to substantially expand and differentiate into
hepatocyte-like cells in culture [1–3]. Their maintenance,
growth and differentiation using cytokine and growth factor
supplemented differentiation media, however, are time
consuming and expensive. Furthermore, pluripotent stem
cells, for now, are not considered for cell therapy applica-
tions due to risks of teratoma formation.
Adult extrahepatic tissues and normal postnatal liver
provide an alternative potential source for the generation of
hepatocytes for in vitro studies and cell therapy. Evidence
has been provided that adult stem cells from various
extrahepatic sources could occasionally overcome lineage
borders and differentiate into hepatic lineage cells, upon
coordinated in vitro stimulation [4,5]. The number of stem/
progenitor cells, that can be isolated from normal adult
liver, is generally low and not sufficient for most of the in
vitro and in vivo applications.
Protocols have thus been developed to expand colonies of
primitive cells with bipotential progenitor characteristics
from cell surface marker enriched populations or directly
from primary hepatocyte cultures. Those cells being desig-
nated here as adult liver-derived progenitor cells (ALDPC),
have first been described as BAML (bipotential adult mouse
liver cells) [6,7] or, from humans, as liver epithelial cells
(LEC [8]), nonparenchymal epithelial cells (NPE [9]) or
human liver progenitor cells [10]. ALDPCs express cytoker-
atins characteristic both for the hepatic (CK8 and CK18) as
well as for the cholangiocytic lineage (CK7 and 19), but lack
many hepatocyte specific functions. Most of the convention-
al differentiation protocols for stem/progenitor cells aim to
induce transcriptional changes by external stimuli and
signals. Target cell populations are cultured on various
extracellular matrix components and in the presence of
media supplemented with cytokines and hormones for a
prolonged period of time [11]. Despite remarkable progress
and refinement of the protocols, adult stem/progenitor cells
often fail to achieve complete function sufficient for
regenerative therapy and toxicological assays, remaining
only "hepatocyte-like".
An alternative experimental approach that “engineers”
cell fate and phenotype changes by single or combinatorial
ectopic over-expression of key transcription factors in target
cell populations, evolved over the past several years. Ber
et al. were the first to demonstrate that insulin producingbeta cells can be generated from developmentally related
hepatocytes by transfer of a single transcription factor PDX-1
[12]. Takahashi and Yamanaka successfully re-programmed
mouse embryonic/adult fibroblasts into ES-like stem cells,
referred to as iPS cells, by retroviral transfer of the
transcription factors Oct4, Sox2, c-Myc and Klf4 [13].
Recently, Vierbuchen et al. were able to convert mouse
embryonic and postnatal fibroblasts directly into partially
functional neuronal cells by ectopic expression of three
transcription factors (Ascl1, Brn2 -also called Pou3f2- and
Myt1l) thereby bypassing the state of pluripotency [14]. By a
similar approach, Ieda et al. have successfully repro-
grammed cardiac or dermal fibroblasts directly into cardio-
myocyte-like cells by a combination of three developmental
transcription factors [15].
Induction and maintenance of hepatocyte differentiation
and control of liver-specific gene expression is attributed, in
large part, to the coordinated expression of liver enriched
transcription factors (LETFs) [16,17]. This class of proteins
includes five families of transcriptional regulators: Hnf1,
Foxa (Hnf3), Hnf4, Hnf6 and C/ebp [18,19]. While none of
these factors is exclusively expressed in the liver, the
combinatorial actions of tissue-specific transcription factors
lead to the stringency and dynamic regulation of gene
expression required for the proper development and function
of the organ [20]. In our present study, we identified three
transcription factors, which upon sequential ectopic over-
expression confer an advanced mature hepatocyte pheno-
type in an adult liver derived clonal cell population. The
three transcription factors expressed in ALDPCs (Foxa2,
Hnf4α and C/ebpα) were selected based on their already
known functions in liver development and maturation in
combination with the finding of their rapid downregulation
during the first days of primary hepatocyte culture - thus
provoking experiments to reintroduce them to achieve
maturation again.Results
Functional expression of Foxa2, Hnf4α and C/ebpα
First, a series of transfection experiments in HEK293T cells
utilizing a luciferase reporter assay was carried out to
validate functional expression of the cloned transcription
factors Foxa2, Hnf4α and C/ebpα in their final, lentiviral
expression plasmid context (Fig. 1).
Basically, the transcription factor under investigation is
expected to have a transcription inhibitory (Foxa2) or
promoting (Hnf4α, C/ebpα) activity upon the promoter of the
respective luciferase expression plasmid, thus resulting in
luciferase signal changes compared to controls. A third
cotransfected plasmid, carrying a Renilla-luciferase expression
Figure 1 Functional luciferase assay for transcription factors. A) Inhibition of luciferase expression by Foxa2: The lentiviral vector
plasmid Foxa2-IRES-puro was cotransfected with the plasmids pTCF-CMVpro-GL4.20. B) Induction of luciferase expression by Hnf4α
and C/ebpα: The lentiviral vector plasmids pL-S-Hnf4a-I-egfp and pL-S-Cebpa-I-dTom (Suppl. Fig. 1) were co-transfected with a
Ugt1a9-promoter-luciferase construct. In all experiments a cotransfected Renilla-luciferase expression plasmid served to normalize
for transfection efficacy. Corresponding lentiviral vector plasmids without transcription factor ORF served as controls (Puromycin,
eGFP, dTomato). Data show the mean value (N=3) and the standard deviation (SD). Statistical analysis: Student's T Test.
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for transfection efficiency.
For the Foxa2 plasmid a 25% decrease in relative
luminescence ratio was detected from a TCF4-CMVpro
promoter reporter plasmid [21] (Fig. 1A) upon transfection.
Hnf4α and C/ebpα lentiviral plasmids induced significant
luminescence from a Ugt1a9 promoter reporter plasmid [22],
resulting in a 66% and 167% increase in Firefly/Renilla
luminescence ratio, respectively (Fig. 1B).
Adult liver derived progenitor cells (ALDPC) transduced
with each lentiviral vector showed increased mRNA levels of
the respective transcription factor (Fig. 2), with expression
levels in triple-transduced cells being in the same range as
mRNA levels found in freshly isolated hepatocytes (pHc
day 0).
Foxa2 transgenic ALDPC were also transduced with C/ebpα
only. However, in the absence of elevated levels of
(cotransduced) Hnf4α, C/ebpα appeared cytotoxic in our
system - dTomato positive cells no longer adhered to the
collagen coating and died subsequently in suspension, as
indicated by their rapid loss of dTomato-flourescence. Thus
the experimental use of ALDPC-F-C for mRNA-expression,
protein secretion and metabolic analyses was not feasable in
our hands (data not shown).Characterisation and maturation of
untransduced ALDPC
ALDPCs were derived from several primary liver cell cultures
in maintenance medium (MM) containing EGF, IGFII and
insulin. A tightly packed monolayer of cells was formed after
three to six weeks of culture. The ALDPC population we used
expressed keratins 7, 8, 18 and 19 mRNAs, detectable, albeit
low levels of liver enriched transcription factor mRNA´sincluding Foxa2, Hnf1α and Hnf4α and no detectable levels
of C/ebpα mRNA (Fig. 2, ALDPC-MM and Supplementary
Fig. 2). Only trace amounts of albumin and α1-antitrypsin
were secreted into the supernatant. Furthermore, no
α-fetoprotein (Afp) expression could be detected (data not
shown). From the 15 mRNAs chosen to measure differential
expression in mouse hepatocytes, none - if at all - was
detectable at a range comparable to primary hepatocyte
controls (Fig. 3, ALDPC-MM).
Seven days after induction of ALDPC maturation by using
collagen I-coating and LD-medium, mRNA levels for tran-
scription factors Foxa2, Hnf4α mRNA were upregulated, also
C/ebpα became detectable (Fig. 2, columns ALDPC). Also
increased levels of Alb, Aat, Cldn1, Fah, Pxr, Apoa1, Apoa4
and Apoc3 (Fig. 3, columns ALDPC-MM vs. ALDPC) were
measured. Furthermore, Tdo2, G6p, Cps1 and Gys mRNAs
were consistently - albeit with considerable variation -
detected in the ct-range between 35 and 40 under
maturation conditions, whereas in MM-conditions mRNAs
could not be detected in our PCR-settings (data not shown).
With the exception of the cytochrome p450 genes and Tat,
all genes tested were upregulated by cultivation of ALDPC
under differentiation conditions as compared to standard
maintenance conditions - at least 2-fold (Cldn1, Pxr) up to
more than 100-fold (Alb, Apoa1) - or became first detectable
at all. Apoa1 and Fah could be induced to levels comparable
to the primary hepatocyte day 1 controls.
No significant signals for secreted Albumin and Aat were
detected after an maturation-induction period of 7 days
(Fig. 4). Only marginal ureagenic ability (Fig. 5) and glycogen
storage ability (data not shown) could be measured upon
induction. The findings indicate limitations of conventional
differentiation protocols towards hepatocyte maturity in
vitro, in particular in comparison with a primary hepatocyte
standard.
Figure 2 Transcription factor mRNA levels. RT-qPCR analysis at
day 7 of the respective treatment. Expression levels of Foxa2
(upper panel), Hnf4α (middle), C/ebpα (lower). Bars are grouped
into 1) primary hepatocyte controls: pHc day 0, primary murine
hepatocytes freshly isolated without cultivation; pHC day 1,
primaryhepatocytes in culture 24 hours after isolation; 2) untrans-
duced ALDPC: ALDPC-MM, ALDPC in maintenance medium;
ALDPC, ALDPC in liver differentiation medium (LD); 3) transcrip-
tion factor transduced ALDPC-F, ALDPC-F-H and ALDPC-F-H-C:
ALDPC in LD medium, transduced with -F:Foxa2, -H:Hnf4α, -C:C/
ebpα. The data show mRNA levels normalized to Gapdh as the
internal standard. Data are expressed as mean of three
independent experiments±standard deviation (SD).
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ectopic expression of transcription factors
The concept of maturation induction by sequential expres-
sion of defined transcription factors was tested in Foxa2
transgenic ALDPCs by lentiviral transduction of Hnf4α and C/
ebpα, using the described vectors and LDmedium. At the end
of the differentiation protocol (day 7 after transduction),flow cytometry analysis indicated 87% eGFP positive, 60%
dTomato positive and 34% double positive cells (mean of a
set of 3 independent transduction experiments). The
morphology of double and triple transduced cells most
closely resembled adult mouse hepatocytes (Fig. 6). ALDPCs
in LD medium and Foxa2 over-expressing ALDPCs maintained
the proliferative phenotype, consisting of small mononucle-
ated cells. Double and triple transduction induced a major
morphological change, which was evident from day three
post-transduction. Cells increased significantly in size with
an obvious effect on the nucleus-to-cytoplasm ratio. The
cytoplasm appeared more complex, some cells became
binucleated, resembling primary adult hepatocytes (Fig. 6C
and D). Morphological changes were accompanied by a strong
proliferation arrest induced by high levels of transduced
Hnf4α, as indicated by microscopy and EdU nucleotide
incorporation (data not shown) and transduced C/ebpα
(albeit difficult to verify because of its above mentioned
cytotoxicity in ALDPC-F-C, data not shown). The findings
confirm previous reports on proliferation-inhibitory effects
of Hnf4α [23–25] and C/ebpα [26,27].
The combinatorial actions of the three transcription
factors induced major morphological effects also observed
in ALDPC (increase in size, binucleation and growth arrest) in
the fibroblast cell line NIH3T3 (Supplementary Fig. 3, A-D).Liver specific gene expression analysis
All of the 15 genes representing a wide range of hepatocyte
functions were significantly induced in at least one of the
transcription factor combinations used (Fig. 3). Expression
levels similar to hepatocyte controls were obtained for Alb in
Foxa2 transduced cells, but lower in double or triple
transduced cells. This is consistent with the fact that Foxa2
is a transcriptional activator of Alb and with our observation
that Foxa2 levels decreased when cells are cotransduced
with Hnf4α (Fig. 2). Aat, Tdo2, Cldn1, Cps1, ApoA4 achieved
highest expression levels - comparable to hepatocytes - in
the triple transduced group. In the LETF transduction group,
expression of G6p, Fah, Pxr, ApoA1 was higher than in
primary hepatocytes cultured for 24 hours, approaching
levels of freshly isolated hepatocytes (data not shown).
Also, Tat, Gys2, Cyp2a5 and Cyp3a11 showed highest
expression levels in the triple transduced group - however,
reduced compared to the primary hepatocyte day 1
standard. Apart from Apoa1 and Apoa4, expression levels
of freshly isolated hepatocytes on day 0 could not be reached
by any of the experimental settings.
Transcription factor-transduced NIH-3 T3 cells, exhibiting
pronounced changes towards a hepotocyte-like, epithelial
morphology and positivity for PAS-staining (Supplementary
Fig. 3), upregulated Tdo2 and G6p to levels in the ranges of
ALDPC-F-H-C or primary hepatocytes (Supplementary Fig. 4).
Alb and Aat, not measurable in untransduced NIH3T3,
became detectable.
iPS-derived hepatocyte-like cells, albeit in some cases
with considerable variation between the three independent
samples, showed Alb-mRNA levels similar to ALDPCs in
maturation conditions (Supplementary Fig. 4). Tdo2, G6p,
and Cldn1 levels exceeded expression detected in ALDPC-F-
H-C or primary hepatocytes.
Figure 3 mRNA expression levels of liver genes. RT-qPCR analysis for mRNA levels of the 15 genes indicated at day 7 of the
respective treatment. Bars are grouped into 1) untransduced ALDPC: ALDPC-MM, ALDPC in maintenance medium, ALDPC, ALDPC in
liver differentiation medium (LD); 2) transcription factor transduced ALDPC-F, ALDPC-F-H and ALDPC-F-H-C: ALDPC in liver
differentiation medium (LD), transduced with -F:Foxa2, -H:Hnf4α, -C:C/ebpα; 3) Standard: pHc day 1, primary human hepatocytes in
culture (LD medium) 24 hours after isolation and pHc day 0, immediately after isolation. The data show mRNA levels normalized to
Gapdh as the internal standard. Data are expressed as mean of three independent experiments±standard deviation (SD). Statistical
analysis: Student Test, *Pb0,05, **Pb0,01.
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Figure 4 ELISA for protein secretion into the supernatant. A) ELISA for albumin release. B) mouse alpha-1 antritypsin ELISA. The
release of 1x106 cells into 1 ml of medium for 24 hours was assayed. The data in A and B show results from three independent
experiments (mean value±SD). pHc: primary hepatocytes in culture 24 hours after isolation; ADLPC, ALDPC-F, ALDPC-F-H and ALDPC-
F-H-C: ALDPC in liver differentiation medium (LD), transduced with -F:Foxa2, -H:Hnf4α, -C:C/ebpα.
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Compared to baseline, Alb secretion levels increased
stepwise in single, double and triple transduced ALDPCs
(Fig. 4A). Triple transduced cells secreted albumin at levels
comparable to the concentrations measured in supernatants
of 24 h cultured primary hepatocytes.
In contrast, Aat protein secretion reached mature
hepatocyte levels already following Foxa2 transduction and
was not further stimulated in the double or triple transduced
cell populations (Fig. 4B).
Ureagenesis was not detectable above background in non-
transduced ALDPCs but elevated in transduced cells at day 7
(Fig. 5). Foxa2 transduction of ALDPCs appeared to beFigure 5 Analysis of urea production. Urea release of 1x106
cells into 1 ml of supernatant over 24 hours. The data show results
from three independent experiments (mean value±SD). pHc:
primary hepatocytes in culture 24 hours after isolation; ALDPC,
ALDPC-F, ALDPC-F-H and ALDPC-F-H-C: ALDPC in liver differ-
entiation medium (LD), transduced with -F:Foxa2, -H:Hnf4α,
-C:C/ebpα.sufficient to induce ureagenesis. However, urea production
was still considerably lower than in the hepatocyte standard.
Storage of glycogen is a characteristic feature of mature
hepatocytes. We thus stained primary mouse hepatocytes
and ALDPCs with PAS. Non-transduced or Foxa2 transgenic
ALDPCs showed inconsistent PAS staining. Double transduced
or triple transduced cells presented a bright PAS positive
staining, similar to hepatocyte controls, concordant with
findings of Gys2 mRNA upregulation for those settings.
Particularly, cells closely resembling adult hepatocytes by
morphology also presented the brightest PAS positive
staining. (Fig. 7). Also, transcription factor-transduced
NIH3T3 fibroblasts stained positive for PAS (Supplementary
Fig. 4, F).Discussion
Our data show that terminal hepatic differentiation in vitro
can be improved by sequential over-expression of the three
transcriptional regulators Foxa2, Hnf4α and C/ebpα. Epi-
thelial morphology, hepatic gene expression, secretory
function and metabolic activity were reproducibly induced
in an expandable adult progenitor cell population after a
period of seven days in culture. Protein secretion rates,
mRNA expression levels of the 15 representative genes, as
well as glycogen production were closing up or even similar
to values reached by 24 hours cultured primary mouse
hepatocytes. However, RNA expression levels of freshly
isolated hepatocytes (day 0) were still superior.
The cells used in our studies appear reliably over time in
primary hepatocyte cultures in the presence of growth factor
supplemented medium and were first described as BAML cells
[6]. Whether they already pre-exist as stem/progenitor cells
in the liver or derive from other cell types in the presence of
growth factors in culture, is currently not known. Terminal
differentiation of those cells under adherent culture condi-
tions in vitro, using standard maturation conditions (a
variety of conditions from previous reports were tested
Figure 6 Morphology of untransduced and transduced ALDPC. A) untransduced (MM medium). B) Foxa2 transduced ALDPC (LD
medium, day 7). C) Foxa2 transgenic ALDPCs transduced with the lentivirus Hnf4α-IRES-eGFP (LD medium, day 7). D) Foxa2 transgenic
ALDPCs co-transduced with the lentiviruses Hnf4α-IRES-eGFP and C/ebpα-IRES-dTomato (LD medium, day 7).
257ALDPC by ectopic expression of transcription factorsbeforehand) was limited, resulting in induction of hepatic
gene expression and hepatocyte functions but not reaching
primary hepatocyte ranges.Figure 7 PAS-staining for glycogen storage. pHc: primary hepatocy
H and ALDPC-F-H-C: ALDPC in liver differentiation medium (LD), traFor further improvement of hepatic terminal differenti-
ation, we followed a strategy of ectopic sequential expres-
sion of a combination of transcription factors. First, wetes in culture 24 hours after isolation; ALDPC, ALDPC-F, ALDPC-F-
nsduced with -F:Foxa2, -H:Hnf4α, -C:C/ebpα.
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Foxa2. Foxa transcription factors are required for normal
development of endoderm derived organs such as liver and
pancreas [28]. Recent studies identified that Foxa proteins
act as “competence factors” and facilitate binding and
transcriptional activity of other transcription factors in
endoderm cells and tissues [28]. Moreover, it has been
shown that Foxa2 is required for normal liver homeostasis
also in the adult liver, as N43% of genes expressed in the liver
were associated with Foxa2 binding [29]. Standard liver
differentiation conditions were sufficient to maximally
induce secretion of Aat in Foxa2 transgenic cells. In contrast,
we have observed an incremental increase in albumin
secretion in single, double and triple transduced cells,
whereas albumin-mRNA levels already peaked in the Foxa2-
only setting, indicating that maturation of specific secretory
functions requires elevated levels of Hnf4α and C/ebpα, too.
Ishii et al. recently demonstrated enhanced expression of
Albumin, Afp, Tat and epithelial cell adhesion molecule
(Epcam) genes in bone marrow derived mesenchymal stromal
cells over-expressing only Foxa2. The differentiated cells
also showed hepatocyte-specific functions including glyco-
gen production and urea secretion, compared to HUH-7 or
HepG2 controls, but no comparison was made with adult
primary human hepatocytes [21].
In a second step, Foxa2 transgenic ALDPC were co-
transduced with lentiviral vectors expressing either Hnf4α
or C/ebpα. The hepatocyte nuclear factor 4α is known as a
key regulator of both hepatocyte differentiation during
embryonic development and maintenance of a differentiat-
ed phenotype in the adult liver [30,31]. Recent studies using
hepatocyte-specific Hnf4α-knockout mice have shown that
Hnf4α is essential for the generation of hepatic epithelium
[31]. The CCAAT/enhancer-binding protein alpha (C/ebpα)
maintains the differentiated state of hepatocytes and directs
transcription of many genes expressed in the liver such as
albumin or ornithine cycle enzymes involved in urea
production. Conditional knockdown of C/ebpα revealed an
important role in hepatic glucose, nitrogen, bile acid and
iron metabolism - all of which represent highly differentiated
hepatocyte functions [28]. Cultures of ALDPC transduced with
Foxa2, Hnf4α and C/ebpα adopted an epithelial morphology
and contained more cells with two or more nuclei, which is a
hallmark of adult hepatocytes (Figs. 6 and 7) and indicative of
inhibition of full cell division.
The expression of liver specific genes in triple transduced
ALDPCs approached in many cases levels in the range of the
primary hepatocyte day 1 standard (Fig. 3). However, some
genes like CYP450 enzymes and Apoc3, although maximally
induced in triple transduced cells, have proven to be difficult
to up-regulate to levels found in primary hepatocytes.
Expression of additional transcription factors, the applica-
tion of histone deacetylase inhibitors, which have been
shown to improve hepatic differentiation of ESCs, and in
particular three dimensional culture systems allowing the
formation of organ-like epithelial structures, might be
required in order to maximally induce the expression of
those genes.
Although the triple transduced cells exhibit gene expres-
sion and protein secretion levels comparable with a mature
hepatic phenotype, more complex metabolic functions of
hepatocytes such as ureagenesis were still sub-optimal.Expression of carbamoylphosphate synthase-1 (Cps1), a rate-
limiting enzyme in urea synthesis, was reported to be
strongly decreased in the absence of C/ebpα [32,33]. In
triple transduced ALDPCs Cps1 was highly induced, but over-
expression of C/ebpα appeared not sufficient to upregulate
ureagenesis in the range of primary hepatocytes (Fig. 5).
With our triple transduction protocol, partial induction of
a liver phenotype across lineage borders could be observed in
NIH3T3 cells, as seen by morphological changes towards an
epithelial phenotype (Supplementary Fig. 3) and partial
induction of mRNA expression for liver specific genes
(Supplementary Fig. 4). The finding, that the three tran-
scription factors led to some changes towards a hepatocyte-
like phenotype even in NIH3T3, also indicates their impor-
tance for hepatocyte development and terminal
differentiation.
iPS-derived hepatocyte-like cells reached either inter-
mediate gene expression levels or in the range of (or even
exceeding) primary hepatocytes (Supplementary Fig. 4). It
remains to be seen whether transcription factor transduction
will improve terminal maturation of iPS-derived hepatocyte-
like cells.
The current protocol utilizing constitutive expression of
the transcription factors is not compatible with the
application of differentiated ALDPCs for cell therapy. Both
Hnf4α and C/ebpα inhibit proliferation [23–27] and thus
would interfere with organ repopulation in vivo. Indeed, a
major phenotypic change from a proliferative phenotype to a
differentiated hepatocyte-like phenotype was only noted
when the transgenic Foxa2 ALDPCs have been further co-
transduced with growth inhibitory Hnf4α and C/ebpα. In
future studies, using human adult liver progenitor cells and
human transcription factors - building upon the studies
presented here, vectors with inducible transcription factor
expression will be tested. Proliferative Foxa2-transgenic
human liver progenitors, already carrying inducible Hnf4α
and C/ebpα transgenes might be useful for in vitro drug- and
drug-toxicity testing as well as for the colonization and
subsequent inducible operation of bioartificial liver support
devices.
In conclusion, we have shown that sequential ectopic
expression of Foxa2, Hnf4α and C/ebpα induces a hepato-
cyte phenotype of significantly advanced maturity in an
expandable liver derived progenitor cell line. Our rapid
differentiation protocol might provide the means to gener-
ate reliable cell sources for in vitro basic cell research, drug
testing studies and bioartificial liver support devices in the
future.Materials and Methods
Study design
The murine liver enriched transcription factors Foxa2, Hnf4α
and C/ebpα were cloned into lentiviral vectors and
expressed in liver derived progenitor cells using a two step
protocol. First, a Foxa2 transgenic ALDPC cell line was
generated under puromycine selection. Terminal hepatic
differentiation was induced in a 7 day protocol by co-
transducing the Foxa2 transgenic ALDPCs with Hnf4α and
C/ebpα. Hepatic differentiation of transduced and non-
259ALDPC by ectopic expression of transcription factorstransduced cells was assesed by mRNA expression quantifi-
cation and standard functional assays and compared to
primary hepatocytes 24 hours in culture. In addition,
maturation induction in triple transduced ALDPCs was also
compared to iPS-derived hepatocyte-like cells and triple
transduced NIH-3 T3 cells.
Lentivirus vectors
The sequences of the murine transcription factors were
amplified from a commercial full ORF (Open Reading Frame)
Shuttle Clone (Foxa2, C/ebpα from ImaGenes, Berlin,
Germany) and an adult mouse liver cDNA sample (Hnf4α),
and inserted into the BamHI cloning site of a 3 rd generation
lentiviral expression plasmid containing a SFFV promoter
driven IRES-Puro (Foxa2, vector plasmid pL-S-Foxa2-I-puro),
IRES-dTomato (C/ebpα, pL-S-Cebpa-I-dTom) or IRES-eGFP
(Hnf4α, pL-S-Hnf4α-I-egfp) expression cassette, respectively
(Supplementary Fig. 1). The correctness of inserts and
cloning procedures was verified by restriction enzyme
digestion and sequencing (SeqLab, Göttingen, Germany)
before virus production. Lentiviruses carrying the transcrip-
tion factor cDNA´s and the respective “empty” controls -
encoding solely for the marker genes puro, eGFP, dTomato -
were produced by transient four plasmid transfection of
HEK293T cells and enriched as described earlier [34]. Virus
titers were calculated from transduction of NIH-3 T3 cells
(DSMZ, Braunschweig, Germany) using increments of the
enriched culture supernatants.
Transcription factor reporter assays
In order to verify functionality of the ectopically expressed
transcription factors, transfection assays were performed
using the Dual Luciferase reporter assay system according to
the manufacturers protocol (Promega). For evaluation of
Foxa2 functional activity, the plasmids pTCF4-CMVpro-
GL4.20 (luciferase expression under control of a promoter
with a negative Foxa2 element) and pL-S-Foxa2-I-puro were
used based on a previous report [21]. Using this system it has
been shown that overexpression of Foxa2 downregulates
Wnt/β-catenin signalling, resulting in a decreased Firefly/
Renilla luminescence ratio [21]. For estimation of the Hnf4α
and C/ebpα transcriptional activities, a luciferase reporter
plasmid (pGL3-basic) containing a 530 bp sequence from the
Ugt1a9 promoter [22] was used in combination with the
plasmids pL-S-Hnf4a-I-egfp or pL-S-C/ebpa-I-dTom. It has
been shown that Hnf4α directly activates the promoter of
Ugt1a9 [35]) and that C/ebpα is an essential transcriptional
upregulator of UDP glucuronosyltransferase expression in the
liver [36].
For the dual luciferase reporter assay, 5x104 HEK293T
cells were transfected at 70% confluency in 12-well plates
with 1,5 μg lipofectamine (Invitrogen) complexed DNA/well
(1:1 ratio of the lentiviral and the respective luciferase
reporter plasmid). The plasmids pGL4.74[hRLuc/TK]ΔTCF
[21] or pRL-TK (Promega) expressing Renilla luciferase
(19,8 ng/well) were co-transfected as internal transfection
controls. Control experiments have demonstrated before,
that none of the three transcription factors had influence on
TK-promoter activity (data not shown). The plasmids pL-S-I-puro, pL-S-I-egfp and pL-S-I-dTom plasmids were used as
transcription factor negative controls (Supplementary
Fig. 1). All experiments were performed in triplicates.
Firefly/Renilla luminescence ratio was analyzed 36 hours
after transfection.
Primary hepatocytes and adult liver derived
progenitor cells
Adult mouse hepatocytes were isolated by a modified 2-step
collagenase perfusion from 2–6 month-old C57BL/6 mice as
previously described by Seglen et al. with minor modifica-
tions [37]. Fresh hepatocyte RNA samples were taken either
immediately for day 0 measurements or after cultivation for
24 hours on collagen I-coated plates in LD medium (described
below) for day 1-RT-qPCR.
Adult liver derived progenitor cells (ALDPC) were
obtained from cultured adult mouse liver cell suspensions
by the “plate and wait” technique, according to published
protocols [7]. After separation of distinct colonies by
trypsination from other colonies, (see Supplementary
Fig. 2A, 30 days) homogeneous cell cultures of ALDPC´s
were generated and substantially expanded using Williams' E
medium supplemented with 10% FCS (PAA), 50 ng/ml
epidermal growth factor (EGF, PeproTech), 30 ng/ml insu-
lin-like growth factor II (IGFII, PeproTech) and 10 ng/ml
insulin (Sigma-Aldrich), designated as maintenance medium
(MM). For our hepatic differentiation experiments, the
ALDPC clone E was used at passage 40. At this passage the
cells were actively growing, requiring 1:5 splitting every
3 days. No morphological and changes of growth and gene
expression properties could be observed up to at least
passage 60.
Hepatic maturation was induced in adherent clone E cells
over a period of 7 days. Cells were seeded at a density of
1.5×105 cells/well in rat tail collagen I-coated 6 well plates
(Roche) using liver differentiation medium (LD), consisting of
HBM (Lonza) supplemented with the "standard single quots"
of insulin, hydrocortisone, transferrin, ascorbic acid, anti-
biotics according to the manufacturers instructions (Lonza,
HCM single quots) and mouse hepatocyte growth factor
(HGF, 20 ng/ml, R&D Systems).
Transcription factor transduction
In a first transduction step, Foxa2 transgenic ALDPC cells
were generated by transducing passage no. 40 expanded
ALDPCs with the Foxa2 lentivirus at an MOI (multiplicity of
infection) of approximately 0.3. Transduction was followed
by puromycin selection (2 μg/ml). After selection, cells were
kept in MM containing 1 μg/ml puromycin (see 4.4). For
experimental use, Foxa2-transduced ALDPC were treated
the same as ALDPC for maturation induction, described in 4.4
without further puromycine supplementation.
In a second transduction step, 1.5×105 Foxa2 transgenic
ALDPC's were seeded on rat tail collagen I-coated (Roche) 6
well plates, cultured in LD medium and co-transduced with
either L-S-Hnf4a-I-egfp and L-S-Cebpa-I-dTom or with L-S-I-
egfp and L-S-I-dTom control lentiviruses. An MOI of 1,5 was
used for transduction. Single transductions with L-S-Hnf4a-I-
egfp or L-S-Cebpa-I-dTom were also included. Subsequent
260 R. Iacob et al.analyses were consistently performed at day 7 post matura-
tion induction and lentiviral transduction.RNA extraction and quantitative real time PCR
Total RNA from freshly isolated mouse hepatocytes, 24 hours
cultured mouse hepatocytes, ALDPCs, was extracted using
the RNeasy Mini kit (Qiagen) and subjected to reverse
transcription using iScript cDNA synthesis kit (Biorad). The
messenger RNA (mRNA) expression levels were determined
by quantitative RT-PCR using a LightCycler 480 System
(Roche) and gene specific primers (Supplementary
Table 1). Absolute quantification analyses were performed
using the Second Derivative Maximum Method. PCR reactions
were run for 45 cyles, however, ct-values above 35 were
regarded as unsafe and not used for graphical depiction,
according to the MIQE guidelines [38]. For standardization of
the RT-qPCR analysis, the PCR fragment of each gene was
cloned into the pCR4-Topo vector (Invitrogen) and se-
quenced. Standard curves for all template-primer pair
combinations were generated by diluting equal starting
concentrations of the plasmids in a pooled sample. The
mRNA-values were calculated from the standard curves and
normalized to Gapdh mRNA expression.Enzyme linked immunosorbent assay
The amount of albumin secretion was quantified by sandwich
enzyme linked immunosorbent assay using a mouse albumin
ELISA quantitation kit according to the manufacturers
protocol (Bethyl Laboratories, TX, USA).
The mouse alpha-1 antitrypsin (mAat) ELISA was per-
formed using cell culture supernatants in 96 well plates (EIA/
RIA 96well, Costar) using a monoclonal antibody against
murine Aat (Abcam). After incubation with a secondary HRP
labelled antibody (Abcam) the substrate TMB/H2O2 was
added. The colour development was stopped with 1 N
sulfuric acid after 30 min. followed by photometric analysis
at 450 nm. Protein secretion studies and mRNA expression
studies were performed simultaneously using the same cell
samples.Analysis of urea production
Ureagenic ability of differentiated cells was assessed using
the QuantiChromTM Urea Assay kit (BioAssay Systems, CA,
USA). ALDPC or hepatocyte cultures were incubated for
24 hours with 5 mM ammonium chloride and the amount of
urea secreted into the culture medium was measured
according to the manufacturer's protocol.PAS staining
The glycogen storage capacity of the differentiated ALDPCs
and control hepatocytes was assessed by PAS staining. Six-
well adherent cell cultures were fixed with 95% ethanol for
10 minutes, treated with periodic acid, stained with Schiff's
reagent and finally counterstained with Meyer's Hemalaun
solution.Statistical analysis
All values given represent the mean values of at least three
independent experiments and the corresponding standard
deviation (SD). Data between study groups were compared
using Student's T-Test. A p-valueb0.05 was considered
statistically significant.
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